As part of DTB’s “Don’t Drop Mixtard” campaign, this podcast discusses the implications of the drug’s withdrawal from the UK market for people with diabetes, healthcare professionals and the NHS.
The conversation involves Dr Wing May Kong (consultant endocrinologist and member of the DTB Editorial Board), Cathy Moulton (Care Adviser at Diabetes UK), and Dr Ike Iheanacho and David Phizackerley (Editor and Deputy Editor of DTB, respectively).
To find out more about the campaign, including DTB’s petition against the withdrawal of Mixtard 30, please go to dtb.bmj.com.
14 Jul, 10 | by BMJ Group
A monthly audio round-up detailing the contents of the latest issue of DTB.
Articles:
Money, money, money
Preventing exacerbations in COPD
Febuxostat for gout
How medical devices are regulated in the UK
In this issue - July 2010 [8:59m]:
14 Apr, 10 | by BMJ Group
This month, we publish the results of a Drug and Therapeutics Bulletin Survey on Herbal Medicines, an online research designed to explore healthcare professionals’ knowledge of and attitudes towards herbal medicines. In this podcast, Dr Ike Iheanacho, DTB Editor, and David Phizackerley, DTB Deputy Editor, discuss the results of the survey, and issues related to the use and regulation herbal medicines, with Dr Linda Anderson, Principal Pharmaceutical Assessor at the MHRA and Mr Michael McIntyre, Chairman of the European Herbal and Traditional Medicine Practitioners Association. The results of DTB Survey on Herbal Medicines are available on our website, dtb.bmj.com.
Standard Podcast [26:51m]: